SPRINGWORKS THERAPEUTICS ($SWTX) posted quarterly earnings results on Thursday, February 20th. The company reported earnings of -$1.04 per share, missing estimates of -$0.68 by $0.36. The company also reported revenue of $61,550,000, beating estimates of $60,299,513 by $1,250,487.
You can see Quiver Quantitative's $SWTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
SPRINGWORKS THERAPEUTICS Insider Trading Activity
SPRINGWORKS THERAPEUTICS insiders have traded $SWTX stock on the open market 21 times in the past 6 months. Of those trades, 0 have been purchases and 21 have been sales.
Here’s a breakdown of recent trading of $SWTX stock by insiders over the last 6 months:
- DANIEL LYNCH has made 0 purchases and 4 sales selling 175,400 shares for an estimated $9,554,351.
- SAQIB ISLAM (Chief Executive Officer) has made 0 purchases and 7 sales selling 156,672 shares for an estimated $7,213,116.
- BADREDDIN EDRIS (Chief Operating Officer) has made 0 purchases and 6 sales selling 70,000 shares for an estimated $3,246,085.
- DANIEL PICHL (Chief People Officer) has made 0 purchases and 3 sales selling 29,750 shares for an estimated $1,617,329.
- JULIE HAMBLETON sold 13,774 shares for an estimated $730,206
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
SPRINGWORKS THERAPEUTICS Hedge Fund Activity
We have seen 115 institutional investors add shares of SPRINGWORKS THERAPEUTICS stock to their portfolio, and 124 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP removed 1,961,830 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $70,880,917
- ECOR1 CAPITAL, LLC added 1,560,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $56,362,800
- ARTAL GROUP S.A. removed 1,313,026 shares (-100.0%) from their portfolio in Q3 2024, for an estimated $42,069,353
- CAPITAL INTERNATIONAL INVESTORS added 1,136,079 shares (+92.7%) to their portfolio in Q4 2024, for an estimated $41,046,534
- PERCEPTIVE ADVISORS LLC removed 692,263 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $25,011,462
- CANDRIAM S.C.A. removed 681,155 shares (-80.6%) from their portfolio in Q4 2024, for an estimated $24,610,130
- MORGAN STANLEY added 558,641 shares (+38.8%) to their portfolio in Q4 2024, for an estimated $20,183,699
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
SPRINGWORKS THERAPEUTICS Congressional Stock Trading
Members of Congress have traded $SWTX stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $SWTX stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 01/29.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
